awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35573019-5D315A1F-C113-4DD4-91B6-6E894914AAB6
Q35573019-5D315A1F-C113-4DD4-91B6-6E894914AAB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35573019-5D315A1F-C113-4DD4-91B6-6E894914AAB6
The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.
P2860
Q35573019-5D315A1F-C113-4DD4-91B6-6E894914AAB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35573019-5D315A1F-C113-4DD4-91B6-6E894914AAB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47e0a1c7dd20d090213f017d60e9193c6245ddbe
P2860
Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis.